
Next-gen sequencing pioneer Illumina says it may soon usher in the era of the $100 genome — which could, in theory, make consumer genomics orders of magnitude more accessible.
CEO Francis deSouza on Monday unveiled a new machine, called the NovaSeq, at this year’s J.P. Morgan Healthcare Conference in San Francisco. He said the machine’s scanning speed has increased to a pace that could unravel the DNA of an entire human genome in an hour.
What is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
Genome sequencing in broiler genetic
I call B.S. They just lost the lawsuit against Oxford Nanopore and now they’re trying to dangle the possibility that they can compete with nanopore’s cost. I really doubt they can with the current technology they’re using.
I’m sorry, but no-one from Illumina has said soon. The NovaSeq will one day be capable of $100 genome, but at the moment, the library prep alone costs $150, and then sequencing comes on top. Best price from NovaSeq is $1000 per genome. It will take years before we hit $100.
See http://www.opiniomics.org/hiseq-move-over-here-comes-nova-a-first-look-at-illumina-novaseq/ for more technical detail